They have discovered that statins, a family of drugs originally developed to lower cholesterol levels, can reduce the risk of dementia by as much as one-quarter. The discovery was made in the early 1970s by Akira Endo, a biochemist working for Tokyo-based Sankyo Company. Besides Sankyo, other …

READ FULL ARTICLE Curated publisher From Forbes